The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Cochlear Implants: Identifying Current Paths through Computational Modelling of MRI Data. The Cochlear implant is an Australian invention (first prototype 1978), leading to the formation of Cochlear Ltd. to commercialise it. Cochlear Ltd. has now delivered implants to over 60,000 people in 70 nations across the world. Copycat companies have arisen overseas, but Cochlear Ltd. remains the market leader, due to their commitment to ongoing R&D. The present project involves magnetic resonance imaging ....Cochlear Implants: Identifying Current Paths through Computational Modelling of MRI Data. The Cochlear implant is an Australian invention (first prototype 1978), leading to the formation of Cochlear Ltd. to commercialise it. Cochlear Ltd. has now delivered implants to over 60,000 people in 70 nations across the world. Copycat companies have arisen overseas, but Cochlear Ltd. remains the market leader, due to their commitment to ongoing R&D. The present project involves magnetic resonance imaging and finite element analysis to study the current leakage pathways in the cranial cavity for the purpose of optimizing the design and placement of the return electrode. The obvious benefit of this is longer battery life. Better understanding of current leakage over other intracranial nerves is the other anticipated benefit.Read moreRead less
Bilateral Cochlear Implants for Children: Does a Second Implant Improve Language, Psychosocial and Other Outcomes? Severe-profound congenital hearing loss engenders significant costs to society. In 2005, specialised education cost -- on average $25,000 per child, loss of productivity cost -- $6.7 billion, and social security benefits were paid to approximately 129,000 individuals who were unemployed due to hearing loss. If bilateral cochlear implantation results in improved language, social dev ....Bilateral Cochlear Implants for Children: Does a Second Implant Improve Language, Psychosocial and Other Outcomes? Severe-profound congenital hearing loss engenders significant costs to society. In 2005, specialised education cost -- on average $25,000 per child, loss of productivity cost -- $6.7 billion, and social security benefits were paid to approximately 129,000 individuals who were unemployed due to hearing loss. If bilateral cochlear implantation results in improved language, social development, and academic outcomes, the community benefits arising will be greatly improved quality of life for these individuals and significant savings to society. In partnership with Cochlear Ltd, this study will provide some of the first data worldwide comparing the effects of an additional implant on language, social and educational outcomes.Read moreRead less
The effect of cochlear implants on cognitive decline in ageing Australians. This project aims to investigate the impact of cochlear implants on cognitive function in elderly people with deafness. Deafness has been found to be independently associated with a 30–40 per cent accelerated rate of cognitive decline in elderly adults. There is currently no effective treatment for cognitive decline. The intended outcomes of this observational study will help us to understand the biological process of co ....The effect of cochlear implants on cognitive decline in ageing Australians. This project aims to investigate the impact of cochlear implants on cognitive function in elderly people with deafness. Deafness has been found to be independently associated with a 30–40 per cent accelerated rate of cognitive decline in elderly adults. There is currently no effective treatment for cognitive decline. The intended outcomes of this observational study will help us to understand the biological process of cognitive decline, whether hearing loss is causal, and whether the process can be altered. These findings should be applicable to all individuals with hearing loss. If cochlear implants delay cognitive decline, this would significantly affect policy, quality of life for the elderly, and the cost to society.Read moreRead less
Developing tests for the early detection of eye disease. Australians have a tradition of innovative design in perimetry. A good example being the Frequency Doubling Technology produced from work performed at the Australian National University. This technology, however, is manufactured by an overseas company (Welch Allyn, NY, USA). The Medmont company is a local perimeter manufacturer and we hope to improve their product with innovative design to yield a distinct marketing advantage. We will cons ....Developing tests for the early detection of eye disease. Australians have a tradition of innovative design in perimetry. A good example being the Frequency Doubling Technology produced from work performed at the Australian National University. This technology, however, is manufactured by an overseas company (Welch Allyn, NY, USA). The Medmont company is a local perimeter manufacturer and we hope to improve their product with innovative design to yield a distinct marketing advantage. We will consider the fundamental issues underlying cone-interactions and methods that stress retinal function. We believe that this approach will have advantages over conventional techniques and prove more sensitive for the early detection of eye disease. However, this is a high risk venture requiring substantial developmental cost and technical commitment by the company. Successful innovation will enhance the company's international penetration, continue the trend for Australians to be seen as leaders in this field and have impact on eye care.Read moreRead less
Gene therapy to enhance auditory prosthesis performance for cochlear implants. The cochlear implant is the most effective neural prosthesis, restoring hearing to the deaf. The research aims to develop a new type of implant compatible with delivery of therapeutic genes to the cells lining the cochlea. Gene therapy DNA constructs will be developed that will enhance neural survival and growth, improving cochlear implant performance. The research will provide advances in understanding how to tran ....Gene therapy to enhance auditory prosthesis performance for cochlear implants. The cochlear implant is the most effective neural prosthesis, restoring hearing to the deaf. The research aims to develop a new type of implant compatible with delivery of therapeutic genes to the cells lining the cochlea. Gene therapy DNA constructs will be developed that will enhance neural survival and growth, improving cochlear implant performance. The research will provide advances in understanding how to transfer genes into cochlear tissue, as well as development of gene cassettes for effective neural repair. The work will advance the field of bionics, an area where Australia is establishing international preeminence.Read moreRead less
Bio-MEMS eye sensor for continuous monitoring of intraocular pressure. Glaucoma is a leading cause of preventable blindness, particularly prevalent in the 60+ population, caused by elevated intraocular pressure (IOP). Current treatment to monitor and prevent glaucoma-related blindness is by lowering IOP with eye-drops, laser therapy or surgery. This project directly benefits our aging population by ensuring independence and quality of life, whilst reducing long-term medical and social costs. By ....Bio-MEMS eye sensor for continuous monitoring of intraocular pressure. Glaucoma is a leading cause of preventable blindness, particularly prevalent in the 60+ population, caused by elevated intraocular pressure (IOP). Current treatment to monitor and prevent glaucoma-related blindness is by lowering IOP with eye-drops, laser therapy or surgery. This project directly benefits our aging population by ensuring independence and quality of life, whilst reducing long-term medical and social costs. By incorporating nanotechnology with ophthalmology we will provide an economic solution to long-term, reliable, home-monitoring of IOP. An implantable IOP sensor, will identify patients requiring more invasive treatment compared with those with less aggressive disease, leading to better health resource utilisation.Read moreRead less
Personalising the management of diabetes care in non-English speaking Australian adults with diabetic retinopathy. Reducing the public health burden of diabetes and diabetic retinopathy for non-English speaking Australians is a major challenge for health care providers, researchers, and health policy makers. In addition to improving self care, eye health, and quality of life, this intervention has considerable potential to deliver substantial savings to the Australian community. It will also pro ....Personalising the management of diabetes care in non-English speaking Australian adults with diabetic retinopathy. Reducing the public health burden of diabetes and diabetic retinopathy for non-English speaking Australians is a major challenge for health care providers, researchers, and health policy makers. In addition to improving self care, eye health, and quality of life, this intervention has considerable potential to deliver substantial savings to the Australian community. It will also provide a novel and valid diabetes management program and contribute to future health policies related to personnel, resources and funding allocated to diabetes, eye care, and rehabilitation. This project will raise the skill of existing diabetes educators and serve to generate closer coordination of care between tertiary eye care services and primary care settings.Read moreRead less
Novel antimicrobial surface coatings for Cochlear implants. The objective of this project is to develop new antimicrobial coatings for materials used to manufacture biomedical devices. Infection associated with the use of biomaterials such as biomedical implants, catheters and orthopaedic prostheses is a major barrier to the use of these devices. The coatings that the project plans to develop are based on novel antimicrobials which have been shown to prevent adhesion and colonisation of biomater ....Novel antimicrobial surface coatings for Cochlear implants. The objective of this project is to develop new antimicrobial coatings for materials used to manufacture biomedical devices. Infection associated with the use of biomaterials such as biomedical implants, catheters and orthopaedic prostheses is a major barrier to the use of these devices. The coatings that the project plans to develop are based on novel antimicrobials which have been shown to prevent adhesion and colonisation of biomaterials by bacteria in vivo. This strategy has the potential to prevent device-related infections and revolutionise the biomaterials industry.Read moreRead less
Using the eye as a window to the central nervous system for improved drug testing. The annual cost of treating brain illnesses is US$250 billion. Each new drug costs about US$900 million to develop. This research will give Pfizer Pty Ltd, the project’s industry partner, a more efficient and direct way of testing whether drugs can get into and affect the brain. This will reduce the cost of drug development, which ultimately means cheaper drugs. The project will develop new technologies to put Aus ....Using the eye as a window to the central nervous system for improved drug testing. The annual cost of treating brain illnesses is US$250 billion. Each new drug costs about US$900 million to develop. This research will give Pfizer Pty Ltd, the project’s industry partner, a more efficient and direct way of testing whether drugs can get into and affect the brain. This will reduce the cost of drug development, which ultimately means cheaper drugs. The project will develop new technologies to put Australia at the forefront of neuropharmaceutical and neuroscience research. A new research platform will foster collaborations with the pharmaceutical industry both within Australia and overseas. This industrial link will promote a unique post-graduate experience by providing exposure to academic and industrial environments for Australian scientists.Read moreRead less
A longitudinal study of language learning to assess early intervention outcomes in pre-school children with impaired hearing. Overseas research suggests that young children with impaired hearing and normal non-verbal cognition can develop normal language if hearing aid fitting and intervention occur before 6 months of age. Australian studies show considerable language delays in most hearing-impaired children of primary-school age. We will study the spoken language learning of hearing-impaired ....A longitudinal study of language learning to assess early intervention outcomes in pre-school children with impaired hearing. Overseas research suggests that young children with impaired hearing and normal non-verbal cognition can develop normal language if hearing aid fitting and intervention occur before 6 months of age. Australian studies show considerable language delays in most hearing-impaired children of primary-school age. We will study the spoken language learning of hearing-impaired children up to age 6 years in Victoria. The project will investigate crucial factors in achieving normal language learning in hard-of-hearing children and the role of early intervention. Normal language outcomes would enhance the educational and career prospects of hearing-impaired children and result in community cost savings.
Read moreRead less